A randomized, double-blind, placebo-controlled, parallel-group study to assess the efficacy, safety, and tolerability of dexpramipexole administered orally for 52 weeks in participants with severe eosinophilic asthma (EXHALE-3)

Supported projects > Supported Project by Private Organizations in Other Countries · 2024

Authors: Özlem GÖKSEL

2024-2026, Supported Project by Private Organizations in Other Countries, R & D Project, Continues